The slip
PARKINSON RECEIPTno. 1551
18 Oct 2026, 01:27 UTCdopamine neurons, braak
predictionZNF837 in dopamine neurons tracks Braak Lewy-body stage
registered0ce8c4550758186d
discovery-0.38 p=0.309 n=9
replication-0.81 p=0.0087 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.38, p 0.309)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT8c2125597e1f0a6f92825a82…
follows 04f114b58ccb…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 1551: ZNF837 in dopamine neurons, braak
- power
- full sample -0.56 (p 0.015, n 18), 95% CI -0.82 to -0.13. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.59 (p 0.010, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.61 (p 0.0077, n 18). not the mix.
- skeptic
- leave-one-out range -0.73 to -0.50, sign flips 0; without severely affected donors -0.56 (p 0.015, n 18). robust.
- cell type
- strongest in oligodendrocytes: -0.61 (p 0.0077, n 18) vs -0.56 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ZNF837 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ZNF837 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.45 p 0.110 (needs p < 9.4e-4)